Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
13.11. | SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient | 291 | PR Newswire | STOCKHOLM, Nov. 13, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin is excited to announce the... ► Artikel lesen | |
12.11. | Notice to extraordinary general meeting in Scibase Holding AB (publ) | 190 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to an extraordinary general meeting to be held... ► Artikel lesen | |
12.11. | SciBase announces collaboration for prediction of atopic dermatitis in infants | 187 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today its... ► Artikel lesen | |
12.11. | SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million | 257 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today decided to carry out a capital raise totaling approximately... ► Artikel lesen | |
12.11. | SciBase: Interim report January 1 - September 30, 2024 | 199 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- January 1 - September 30, 2024
The third quarter in figures
Net sales were TSEK 8,408 (7,248), +16%.The loss after tax was TSEK 17,753... ► Artikel lesen | |
30.10. | SciBase initiates sales collaboration in Italy | 172 | PR Newswire | STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announces today the collaboration... ► Artikel lesen | |
21.10. | SciBase continues US expansion and will attend Fall Clinical conference | 227 | PR Newswire | STOCKHOLM, Oct. 21, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders will attend a leading... ► Artikel lesen | |
14.10. | Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2025 | 283 | PR Newswire | STOCKHOLM, Oct. 14, 2024 /PRNewswire/ -- The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2025:
Anders... ► Artikel lesen | |
SCIBASE Aktie jetzt für 0€ handeln | |||||
27.09. | SciBase announces sale of Nevisense to NIH (US) | 215 | PR Newswire | STOCKHOLM, Sept. 27, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], pioneering prevention and prediction in dermatology disorders is pleased to announce the completion of... ► Artikel lesen | |
26.09. | SciBase expands to new market in Pennsylvania and receives first order from large dermatology practice | 312 | PR Newswire | STOCKHOLM, Sept. 26, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), pioneering prevention and prediction in dermatology announces today a partnership with Seraly Dermatology... ► Artikel lesen | |
02.09. | SciBase: New US Consensus Report supports Nevisense | 268 | PR Newswire | Consensus reached by top US clinicians assessing technologies for melanoma detection and managementThe report concludes that the Nevisense AI-driven technology can significantly enhance early... ► Artikel lesen | |
21.08. | SciBase changes Certified Adviser to Carnegie Investment Bank AB (publ) | 305 | PR Newswire | STOCKHOLM, Aug. 21, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of augmented intelligence-based solutions for skin, hereby announces change... ► Artikel lesen | |
21.08. | SciBase Holding AB: Interim report January 1 - June 30, 2024 | 329 | PR Newswire | STOCKHOLM, Aug. 21, 2024 /PRNewswire/ --
January 1 - June 30, 2024
The second quarter in figures
Net sales were TSEK 6,641 (5,085), +31%.The loss after tax was TSEK 15,050 (11... ► Artikel lesen | |
28.06. | SciBase partner with a large health care group in Los Angeles, Unified Health, and receives a first order | 429 | PR Newswire | STOCKHOLM, June 28, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of augmented intelligence-based solutions for skin disorders announced today... ► Artikel lesen | |
13.06. | SciBase welcomes new chairman and thanks the former | 304 | PR Newswire | STOCKHOLM, June 13, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of AI-based solutions for skin diseases, today announces the election of... ► Artikel lesen | |
13.06. | Annual general meeting has been held in SciBase Holding AB (publ) | 852 | PR Newswire | STOCKHOLM, June 13, 2024 /PRNewswire/ -- Today, the annual general meeting of 2024 was held in SciBase Holding AB (publ) (the "Company" or "SciBase"). Below follows a summary of the resolutions... ► Artikel lesen | |
13.06. | SciBase strengthens the US organization with experienced leader in dermatology | 302 | PR Newswire | STOCKHOLM, June 13, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of AI-based solutions for skin diseases, today announces that Leda Beaty... ► Artikel lesen | |
31.05. | SciBase: Interim report | 273 | PR Newswire | STOCKHOLM, May 31, 2024 /PRNewswire/ -- January 1 -March 31, 2024
The first quarter in figures
Net sales were TSEK 6,057 (5,149), +18%.The loss after tax was TSEK 10,861 (10,906).The... ► Artikel lesen | |
31.05. | SciBase: Today is the first day of trading in the new shares and warrants of series TO 2 issued in connection with the completed capital raising | 268 | PR Newswire | STOCKHOLM, May 31, 2024 /PRNewswire/ -- Today, 31 May 2024, trading in the new shares and warrants of series TO 2 begins, which were issued by SciBase Holding AB (publ) ("SciBase" or the... ► Artikel lesen | |
30.05. | Nasdaq Stockholm AB: New equity right for trading, SciBase Holding ABTO 2 | 260 | GlobeNewswire | At the request of SciBase Holding AB (publ) , SciBase Holdingequity rights will
be traded on First North Growth Market as from May 31, 2024.
Security name: SciBase Holding AB TO 2
---------------------------------------
Short... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ROKU | 65,09 | -0,12 % | Smart Money Is Betting Big In ROKU Options | ||
SERNOVA | 0,167 | +3,85 % | Sernova Aktie: Fortschritte bei Cell Pouch System | Die kanadische Biotechnologiefirma Sernova verzeichnet bedeutende Entwicklungen bei ihrer innovativen Cell Pouch Technologie. Das Unternehmen, das sich auf regenerative Medizinlösungen für chronische... ► Artikel lesen | |
PAUL HARTMANN | 215,00 | +0,94 % | Januar bis September 2024: PAUL HARTMANN setzt positive Geschäftsentwicklung fort - Ergebnisprognose für aktuelles Geschäftsjahr angehoben | Heidenheim (ots) - - Organisches Umsatzwachstum von 3,1 % führt zu Umsatzerlösen in Höhe von 1.796,8 Mio. EUR - Bereinigtes EBITDA von 214,0 Mio. EUR liegt um mehr als 60 Mio. EUR über Vorjahreswert... ► Artikel lesen | |
BOSTON SCIENTIFIC | 87,00 | +1,16 % | Boston Scientific Corporation: Boston Scientific Closes Acquisition of Axonics, Inc. | MARLBOROUGH, Mass., Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq:... ► Artikel lesen | |
ADDLIFE | 11,080 | +0,54 % | AddLife AB: Interim Report 1 January - 30 September 2024 | Organic growth and stable margin while profitability improvement initiatives are progressing
"Continued organic growth and stable margin in the third quarter - a quarter that is normally somewhat weaker... ► Artikel lesen | |
EMBECTA | 12,900 | -0,77 % | Embecta Corp.: embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes | While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D.300-unit insulin reservoir... ► Artikel lesen | |
ENOVIS | 42,400 | 0,00 % | Enovis Corporation: Enovis Announces Third Quarter 2024 Results | Continued commercial momentum with third-quarter sales growth of 21% on a reported basis and strong adjusted EBITDA margin expansionReconstructive sales grew 57% Y/Y on a reported basis and 9% on... ► Artikel lesen | |
R1 RCM | 13,400 | 0,00 % | XFRA 6HL0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILR1 RCM INC. NEW... ► Artikel lesen | |
SYSMEX | 19,000 | +2,70 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen | |
PULMONX | 5,850 | +4,46 % | Pulmonx Corp - 10-Q, Quarterly Report | ||
KANGJI MEDICAL | 0,690 | 0,00 % | Dividendenbekanntmachungen (29.05.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3U HOLDING AG DE0005167902 - 0,05 EUR AAC TECHNOLOGIES HOLDINGS INC ADR US0003041052 0,0108 USD 0,01 EUR AIA GROUP LTD HK0000069689 1... ► Artikel lesen | |
SI-BONE | 11,600 | 0,00 % | SI-BONE-Direktor Jeffrey W. Dunn verkauft Aktien im Wert von 20.001 US-Dollar | ||
REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Strategic Partnership with Sama Therapeutics to Advance Digital Human AI Agents for Precision Mental Health | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO), a leader in comprehensive mental health and wellness... ► Artikel lesen | |
PEIJIA MEDICAL | 0,448 | -3,03 % | PEIJIA-B (09996): VOLUNTARY ANNOUNCEMENT - TAURUSTRIOTM TAVR SYSTEM SUCCESSFULLY COMPLETED THE FIRST COMPASSIONATE USE TREATMENT IN HONG KONG | ||
KOOTH | 1,950 | -2,01 % | Kooth plc (LON:KOO) Insider Acquires £32,000 in Stock |